Our website uses cookies to improve your on-site experience. By using the website, cookies are being used as described in our Policy Document
Warning: To log in you will need to enable cookies and reload the page (Policy Document)
My ePortfolio Register   

Editorial Board

Dr Luca Toschi

Istituto Clinico Humanitas, Milan, Italy

Luca Toschi,MD is a Medical Oncologist currently serving at Humanitas Cancer Center in Milan, Italy, where he is coordinating translational research programs aimed at identifying prognostic and predictive biomarkers in lung cancer. Dr Toschi obtained his Medical Degree at University of Bologna and completed his residency in Medical Oncology at the University of Milan.

In 2001 and 2002 he served as a short term research intern at the International Agency for Research on Cancer in Lyon, France, where he studied genetic aberrations in oxyphilic thyroid tumors. In 2004 he joined the Cytogenetics Core at Colorado Cancer, Aurora, CO as a research intern to investigate the use of Fluorescent In Situ Hybridization in non-small cell lung cancer (NSCLC) patients treated with Epidermal Growth Factor Receptor (EGFR) tyrosine kinase inhibitors. From 2007 to 2010 he served as research fellow at Dana Farber Cancer Institute, Boston, MA in Pasi Jänne laboratory where he focused on the characterization of mechanisms of acquired resistance to EGFR and c-MET inhibitors in NSCLC. Dr Toschi's research has been supported by Associazione Italiana perla Ricercasul Cancro and the International Association for the Study of Lung Cancer.

Founding partners

European Cancer Organisation European Institute of Oncology

Founding Charities

Foundazione Umberto Veronesi Fondazione IEO Swiss Bridge

Published by

ecancer Global Foundation